Eruptive cutaneous squamous cell carcinoma and psoriasis: Response to cetuximab

M. Kamaria, C. R. Shea, R. K. Chin, E. E. Cohen, Ronald Maggiore, D. Bolotin

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Cutaneous squamous cell carcinomas (CSCCs) comprise 20-30% of nonmelanoma skin cancers (NMSCs), and continue to increase in incidence. We report a case of a patient with severe psoriasis who had recurrent and eruptive CSCCs on her leg, which were successfully treated with cetuximab and radiotherapy. The patient had successful long-term clearance of her skin tumours, with the additional finding of resolution of psoriasis while on cetuximab therapy.

Original languageEnglish (US)
Pages (from-to)604-607
Number of pages4
JournalClinical and Experimental Dermatology
Volume39
Issue number5
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Psoriasis
Squamous Cell Carcinoma
Skin
Skin Neoplasms
Leg
Radiotherapy
Incidence
Cetuximab
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Dermatology
  • Medicine(all)

Cite this

Kamaria, M., Shea, C. R., Chin, R. K., Cohen, E. E., Maggiore, R., & Bolotin, D. (2014). Eruptive cutaneous squamous cell carcinoma and psoriasis: Response to cetuximab. Clinical and Experimental Dermatology, 39(5), 604-607. https://doi.org/10.1111/ced.12341

Eruptive cutaneous squamous cell carcinoma and psoriasis : Response to cetuximab. / Kamaria, M.; Shea, C. R.; Chin, R. K.; Cohen, E. E.; Maggiore, Ronald; Bolotin, D.

In: Clinical and Experimental Dermatology, Vol. 39, No. 5, 2014, p. 604-607.

Research output: Contribution to journalArticle

Kamaria, M, Shea, CR, Chin, RK, Cohen, EE, Maggiore, R & Bolotin, D 2014, 'Eruptive cutaneous squamous cell carcinoma and psoriasis: Response to cetuximab', Clinical and Experimental Dermatology, vol. 39, no. 5, pp. 604-607. https://doi.org/10.1111/ced.12341
Kamaria, M. ; Shea, C. R. ; Chin, R. K. ; Cohen, E. E. ; Maggiore, Ronald ; Bolotin, D. / Eruptive cutaneous squamous cell carcinoma and psoriasis : Response to cetuximab. In: Clinical and Experimental Dermatology. 2014 ; Vol. 39, No. 5. pp. 604-607.
@article{34f7754700344d2bad4fd7b9af62a91c,
title = "Eruptive cutaneous squamous cell carcinoma and psoriasis: Response to cetuximab",
abstract = "Cutaneous squamous cell carcinomas (CSCCs) comprise 20-30{\%} of nonmelanoma skin cancers (NMSCs), and continue to increase in incidence. We report a case of a patient with severe psoriasis who had recurrent and eruptive CSCCs on her leg, which were successfully treated with cetuximab and radiotherapy. The patient had successful long-term clearance of her skin tumours, with the additional finding of resolution of psoriasis while on cetuximab therapy.",
author = "M. Kamaria and Shea, {C. R.} and Chin, {R. K.} and Cohen, {E. E.} and Ronald Maggiore and D. Bolotin",
year = "2014",
doi = "10.1111/ced.12341",
language = "English (US)",
volume = "39",
pages = "604--607",
journal = "Clinical and Experimental Dermatology",
issn = "0307-6938",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Eruptive cutaneous squamous cell carcinoma and psoriasis

T2 - Response to cetuximab

AU - Kamaria, M.

AU - Shea, C. R.

AU - Chin, R. K.

AU - Cohen, E. E.

AU - Maggiore, Ronald

AU - Bolotin, D.

PY - 2014

Y1 - 2014

N2 - Cutaneous squamous cell carcinomas (CSCCs) comprise 20-30% of nonmelanoma skin cancers (NMSCs), and continue to increase in incidence. We report a case of a patient with severe psoriasis who had recurrent and eruptive CSCCs on her leg, which were successfully treated with cetuximab and radiotherapy. The patient had successful long-term clearance of her skin tumours, with the additional finding of resolution of psoriasis while on cetuximab therapy.

AB - Cutaneous squamous cell carcinomas (CSCCs) comprise 20-30% of nonmelanoma skin cancers (NMSCs), and continue to increase in incidence. We report a case of a patient with severe psoriasis who had recurrent and eruptive CSCCs on her leg, which were successfully treated with cetuximab and radiotherapy. The patient had successful long-term clearance of her skin tumours, with the additional finding of resolution of psoriasis while on cetuximab therapy.

UR - http://www.scopus.com/inward/record.url?scp=84902553648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902553648&partnerID=8YFLogxK

U2 - 10.1111/ced.12341

DO - 10.1111/ced.12341

M3 - Article

C2 - 24758726

AN - SCOPUS:84902553648

VL - 39

SP - 604

EP - 607

JO - Clinical and Experimental Dermatology

JF - Clinical and Experimental Dermatology

SN - 0307-6938

IS - 5

ER -